On November 14, Centene rose 4.67% in After-Hours Trading, trading at $73.35/share, with turnover of $12.2034 million.
The clearest catalyst was a fresh analyst price-target increase: Truist raised its target to $82 from $80 and maintained a Buy rating, following UBS's earlier move to lift its target to $78 from $70 while keeping a Neutral rating.
The target revisions came after Centene reported stronger third-quarter results on October 27, with adjusted EPS of $0.58 versus a $0.10 consensus estimate and revenue of $50.65 billion versus $47.12 billion expected. The company also raised full-year adjusted EPS guidance to more than $5.20 from more than $4.80, above the $4.87 consensus, reinforcing expectations for a faster earnings recovery and supporting the ongoing valuation reset.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments